Although a minority of GBM patients have leptomeningeal dissemination and distant progression (5.3% and 6.1% of 247 isocitrate dehydrogenase‐wildtype GBM patients, respectively, reported in a study by Jiang et al). The gene discussed is IDH3A; the disease is glioblastoma.